These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6408435)

  • 1. [Biosynthetic human insulin. Comparison of the activity profile of human NPH-insulin and swine NPH-insulin in type I diabetics].
    Etti H; Haupt E
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S53-6. PubMed ID: 6408435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the effects of protamine-bound NPH porcine insulin and NPH human insulin in type 1 and 2 diabetes].
    Renner R; Vocke K; Hepp KD
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1316-20. PubMed ID: 3743441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood sugar profile of various mixtures of regular BHI and basal BHI (NPH) in type I and type II diabetic patients].
    Renner R; Vocke K; Hepp KD
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S57-62. PubMed ID: 6408436
    [No Abstract]   [Full Text] [Related]  

  • 4. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
    Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin analogues and their potential in the management of diabetes mellitus.
    Bolli GB; Di Marchi RD; Park GD; Pramming S; Koivisto VA
    Diabetologia; 1999 Oct; 42(10):1151-67. PubMed ID: 10525654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of fixed-combination preparations of regular BHI and basal BHI (NPH) in type I diabetics].
    Landgraf R; Landgraf-Leurs MM
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S63-8. PubMed ID: 6408437
    [No Abstract]   [Full Text] [Related]  

  • 7. [12 month's therapy with biosynthetic human insulin. Results of a double-blind comparative study with swine and bovine insulin in insulin-dependent diabetics during a multicenter study].
    Beyer J; Haas R; Enzmann F; Lauerbach M; Rademacher J; Althoff PH; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Heun K; Kerp L; Lotz N; Mehnert H; Mitzkat HJ; Petersen K; Rosak C; Sailer D; Schlüter K; Schöffling K; Schröder KE; Schumm P
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S69-79. PubMed ID: 6408438
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
    Rosak C; Jung R; Hofmann U
    Horm Metab Res; 2008 Aug; 40(8):544-8. PubMed ID: 18493882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection.
    Davidson MB
    Diabetes Res Clin Pract; 2004 Jun; 64(3):229. PubMed ID: 15126013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immediate protamine sulphate allergy in an insulin-treated diabetic patient].
    Petäys T; Kiistala R; Mäkinen-Kiljunen S
    Duodecim; 1999; 115(5):517-20. PubMed ID: 11830901
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the absorption and biological activity of NPH human insulin (recombinant DNA) and NPH porcine insulin injected subcutaneously in type II diabetic patients.
    Bannai C; Kawai K; Murayama Y; Yamashita K
    Horm Metab Res; 1986 Nov; 18(11):784-5. PubMed ID: 3539738
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic urticaria from isophane insulin therapy; sensitivity associated with noninsulin components in commercial preparations.
    Shore RN; Shelley WB; Kyle GC
    Arch Dermatol; 1975 Jan; 111(1):94-7. PubMed ID: 1119830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 14. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M; Tapanainen P; Veijola R
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
    Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of insulin of various origins.
    Reeves WG
    Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.